PPJ HEALTHCARE ENTERPRISE, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS PERIOD ENDED (UNAUDITED)

QTR ENDED

QTR ENDED

JUNE 30, 2022

JUNE 30, 2021

__

174,987* $

133,210

Gross sales contract and service revenue

Operating Expenses:

Contract and service cost

101,223

$ 72,012

Marketing expenses

16,000

16,350

Legal expenses

16,052

7,500

Software R&D

0

6,691

Total Operating Expenses

133,275

102,553

Operating Income / Loss

41,712

30,657

Loss on Assets

Net Income

41,712

30,657

Earnings per share

$

(0.00001)

$ (0.0001)

Common shares outstanding

5,305,836,058

5,305,836,058

The accompanying notes are an integral part of these financial statements. *Currently Outsourced

F-1

PPJ HEALTHCARE ENTERPISE, INC.

CONSOLIDATED BALANCE SHEETS ENDED (UNAUDITED)

QUARTER ENDED

QUARTER ENDED

ASSETS

JUNE 30, 2022

JUNE 30, 2021

Current Assets

Cash

$ 487,585

$

521,707

Contracts receivable

1,448,514

1,871,905

Inventory

44,187

30,313

Contingent Asset

13,580,831

12,520,952

Total Current Assets

15,561,117

13,944,877

Equipment

29,200

29,112

Lease deposit

21,015

8,980

Investment in software

933,484

920,984

Total Assets

$ 16,544,816

$14,688,070

Current Liabilities

Accounts payable

27,016

39,621

Due to officers and directors

3,258,138

3,459,138

Lease liabilities (3 years)

78,841

78,841

Note

Loans payable

536,916

531,771

Convertible secured notes w int. ***

288,762

221,893

F-2

Other Loan/Judgments

112,000

112,000

Legal expenses accrued since 2015

22,000

35,000

Other liability from 2006 $1,118,557

0***

0.00

Preferred shares to be issued, zero out

due to the lender's bankruptcy appear to

be finalized

Affiliate Notes Payable (without interest added)

Total Current Liabilities

Total Liabilities

Stockholders' Equity

Class A Preferred Stock, par value

$10.00; 5,000,000 authorized, none issued

Class B Preferred Stock, $2.50 par value, 50,000,000 authorized, 2,118,000 issued and outstanding

Class E Preferred Stock, $0.01 par value, 100,000,000

authorized, 40,005,000 issued and outstanding as of June 30, 2019

F-3

1,540,330

5,864,003

5,864,003

-0-

5,295,000

400,050

1,540,330

5,949,753

5,949,753

-0-

5,295,000

400,050

(30,000,000 Class E Stocks is a Book

Entry on Ms. Basu's name for litigation

expenses).

.

Common Stock, $0.0001 par value;

10,000,000,000 authorized; issued:

December 31, 2016 - 4,035,473,847 shares

AND JUNE 30, 2019 was

4,661,836,058

After Ms. Basu returned

3,400,000,000.

And 400,000,000 converted during

1st qtr of 2019 by GPL Ventures, LLC.

GPL converted another

180,000,000 on 4/5/2019.

As of 9/30/2021 issued and

outstanding Common Stock is

5,305,836,058 @.0009 per

4,775,252

share

Other Comprehensive

10,470,302

Income(expenses)

Total Stockholders' Equity

10,680,813

Total Liabilities and Stockholders'

$ 16,544,816

Equity

15,385,925

6,392,905

8,738,317

$1,4,688,070

The accompanying notes are an integral part of these financial statements.

F-4

PPJ HEALTHCARE ENTERPRISE, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS PERIOD ENDED (UNAUDITED)

Net Revenue

Miscellaneous

Less depreciation

Operating Expenses

Contract and Service Cost

Contracts Receivable Lease Deposit

Contingent Asses

Net Cash Provided by Operating Activities

Investing Activities

Investment in Software

Equipment

Lease Liabilities

JUNE 30, 2022

JUNE 30, 2021

41,71230,657

1,492,701

1,971,905

21,015

8,980

13,580,831

12,520,952

933,984920,984

29,112

78,841

Total Investing Activities

F-5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

PPJ Healthcare Enterprises Inc. published this content on 09 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 August 2022 17:48:05 UTC.